Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
NEW YORK, Nov. 22 /PRNewswire/ -- On November 10, Reynald Bonmati, Chairman and CEO of Orthometrix, Inc. (OTC:OMRX) (BULLETIN BOARD: OMRX) updated the investment community in an all-new...
ORTHOMETRIX, INC. (OTCBB: OMRX) announced today its financial results for the third quarter ended September 30, 2006. Revenue for the third quarter ended September 30, 2006...
Orthometrix, Inc. (OTCBB: OMRX) announced today its financial results for the second quarter ended June 30, 2006. ? Revenue for the second quarter ended June 30, 2006 increased by 82% to $711,956...
ORTHOMETRIX, INC. (OTCBB: OMRX) announced today its financial results for the first quarter ended March 31, 2006. ? Revenue for the first quarter ended March 31, 2006 increased by 59% to $748,066...
ORTHOMETRIX, INC. (OTCBB: OMRX) today announced an alliance with Healthcare Reimbursement Solutions, Inc. of Orlando, Florida ("HRSI") to provide health care providers, such as those...
ORTHOMETRIX, INC. (OTCBB: OMRX) announced today that it started selling in the United States its new Orbasone(TM) ESWT Pain Relief System which received market approval from the U.S. Food and Drug...
ORTHOMETRIX, INC. (OTCBB: OMRX) announced today that its new Orbasone(TM) Pain Relief System received market approval from the U.S. Food and Drug Administration ("FDA") for the treatment of...
ORTHOMETRIX, INC. (OTCBB: OMRX) announced today at the International Foot and Ankle Congress in Toronto, Ontario that its new Orbasone(TM) Pain Relief System received a Medical Device License...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
| 52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 234 | 0.0001 | CS |
| 156 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 1086 | 3.182E-5 | CS |
| 260 | -0.0021 | -95.4545454545 | 0.0022 | 0.01375 | 1.0E-6 | 44332 | 0.00375143 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
